Filing Flows › Comparisons › ASBP vs RGBP
Aspire-Lakewood Holdings vs Regen BioPharma: ASBP and RGBP compared
Aspire-Lakewood Holdings is the larger company: $63K of revenue in its latest quarter (Q2 2026) against $59K for Regen BioPharma (Q3 FY26).
Where the money goes: ASBP and RGBP
Aspire-Lakewood Holdings (ASBP) · Q2 2026
Aspire-Lakewood Holdings, Q2 2026: revenue $63K, net loss $1.3M, operating cash flow −$2.1M. The chart follows the revenue to costs, profit and cash.
Regen BioPharma (RGBP) · Q3 FY26
Regen BioPharma, Q3 FY26: revenue $59K (0% year over year), operating margin 41.5%, net loss $638K, operating cash flow −$24K. The chart follows the revenue to costs, profit and cash.
| Aspire-Lakewood Holdings (ASBP) | Regen BioPharma (RGBP) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 FY26 |
| Revenue | $63K | $59K |
| Revenue growth, Y/Y | — | 0% |
| Operating margin | n/m | 41.5% |
| Net earnings | −$1.3M | −$638K |
| Operating cash flow | −$2.1M | −$24K |
Questions
Which is bigger, Aspire-Lakewood Holdings or Regen BioPharma?
Aspire-Lakewood Holdings is the larger company: $63K of revenue in its latest quarter (Q2 2026) against $59K for Regen BioPharma (Q3 FY26).
More: Aspire-Lakewood Holdings earnings · how Aspire-Lakewood Holdings makes money · Regen BioPharma earnings · how Regen BioPharma makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 17, 2026). Fiscal quarters can end on different dates. Not investment advice.